Under the terms of the settlement, the California company, Medical Marijuana Inc., will take over the hemp-derived Dixie Botanicals (after a ninety-day transition period), leaving Dixie to "develop and expand" its lines of THC-infused products.
"From a consumer perspective, there won't be a difference," says Dixie spokesman Joe Hodas. "This is more a question of two companies dissolving a partnership."
Dixie, however, is still embroiled in a dispute involving the inventor of MED-a-Mints, a popular THC mint candy. The inventor, Gary Gabrel, claims that Dixie violated the contract between them when it changed the MED-a-Mints packaging, making its own name more prominent and removing the words "cannabis infused."
For more on Dixie Elixirs, read our feature story on managing director Tripp Keber.
Follow me on Twitter @MelanieAsmar or e-mail me at [email protected]
